NANS 2020: Abbott Announced Encouraging Results From TRIUMPH And BOLD Follow-Up Studies In Chronic Pain Patients
Follow-up results from the TRIUMPH study and BOLD study of Abbott’s Proclaim XR neurostimulator with BurstDR stimulation waveform were announced at NANS.